Abstract CT193: Tepotinib + gefitinib vs chemotherapy inMET-amplified EGFR-mutant non-small cell lung cancer (NSCLC): Predefined subgroup analysis of a Phase Ib/II study
Year: 2019
Type: conference-abstract
Source: Clinical Trials
Institutions: National Taiwan University Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Seoul National University Hospital, National University Cancer Institute, Singapore, Merck KGaA, Darmstadt (Germany), Samsung Medical Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4238604159